Fortress Biotech (FBIO) Other Non-Current Liabilities (2012 - 2026)

Fortress Biotech's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 17.6% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (down 17.6% YoY), while the FY2025 annual figure was $1.4 million, down 17.6% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $1.4 million, down from $1.6 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $2.1 million in Q3 2021, with the low at $1.4 million in Q4 2025.
• The 5-year median for Other Non-Current Liabilities is $1.8 million (2022), against an average of $1.8 million.
• Peak annual rise in Other Non-Current Liabilities reached 2657.97% in 2021, while the deepest fall reached 74.66% in 2021.
• Fortress Biotech's Other Non-Current Liabilities stood at $2.0 million in 2021, then slipped by 9.15% to $1.8 million in 2022, then climbed by 2.49% to $1.9 million in 2023, then dropped by 7.24% to $1.8 million in 2024, then declined by 17.6% to $1.4 million in 2025.
• Business Quant data shows FBIO's Other Non-Current Liabilities at $1.4 million in Q4 2025, $1.6 million in Q3 2025, and $1.7 million in Q2 2025.